Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02767856 · ClinicalTrials.gov registry record · NA
Regimens of Intermittent Occlusion Therapy for Amblyopia in Children
A NA study, sponsored by Salus University.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02767856 is a NA study that was terminated before completion, run by Salus University. The registered enrollment target is 32 participants.
The verdict
NCT02767856, a NA study, was terminated before completion, sponsored by Salus University.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study is designed to answer the question: What if the Intermittent Occlusion (IO-therapy) glasses were prescribed all day (12-hours) in which the total time of treatment only took 4 weeks instead of the current treatment time (4 hours) in which it takes 12 weeks? Children aged 3- to 8-years with untreated moderate unilateral amblyopia will be enrolled and randomized into 2 groups: 1) Intense 12-hour IO-therapy Group for 4 weeks treatment; or 2) Standard 4-hour IO-therapy glasses Group for 12 weeks treatment.
Interventions
- DEVICE IO-therapy Glasses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-09 |
| Est. Completion | 2021-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02767856
The ClinicalTrials.gov registry entry for NCT02767856 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Salus University, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IO-therapy Glasses is the first listed.
NCT02767856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02767856 about?
NCT02767856 is a clinical study titled "Regimens of Intermittent Occlusion Therapy for Amblyopia in Children". This study is designed to answer the question: What if the Intermittent Occlusion (IO-therapy) glasses were prescribed all day (12-hours) in which the total time of treatment only took 4 weeks instead of the current treatment time (4 hours) in which it takes 12 weeks? Children aged 3- to 8-years wi...
What is the current status of trial NCT02767856?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2016-09. Estimated completion is 2021-05-30.
What interventions are being tested in trial NCT02767856?
The interventions under investigation include: IO-therapy Glasses (DEVICE).
Who is sponsoring clinical trial NCT02767856?
This trial is sponsored by Salus University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.